RYTM fundamentals
Rhythm Pharmaceuticals, Inc. earnings per share and revenue
RYTM earnings per share for the last quarter are -0.72 USD whereas the estimation was -0.69 USD which accounts for -3.81% surprise. Company revenue for the same period amounts to 41.83 M USD despite the estimated figure of 38.48 M USD. Estimated earnings per share for the next quarter are -0.68 USD, and revenue is expected to reach 40.70 M USD. Also watch annual changes over time to get a bigger picture of RYTM earnings per share and revenue dynamics.
Next report date
≈
Report periodQ1 2025
EPS estimate−0.68USD
Revenue estimate40.70 MUSD
EPS
Forecast
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
−2.40
−1.80
−1.20
−0.60
0.00
Reported
Estimate
Currency: USD
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
−0.92
−0.82
−0.76
−0.70
−2.35
−0.55
−0.73
−0.72
—
—
—
—
Estimate
−0.72
−0.80
−0.74
−0.71
−2.36
−0.71
−0.80
−0.69
−0.68
−0.64
−0.62
−0.58
Surprise
−28.22%
−2.79%
−2.70%
+0.79%
+0.27%
+22.41%
+9.27%
−3.81%
—
—
—
—
Revenue
Forecast
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
0.00
15.00 M
30.00 M
45.00 M
60.00 M
Reported
Estimate
Currency: USD
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
11.47 M
19.22 M
22.50 M
24.23 M
25.97 M
29.08 M
33.25 M
41.83 M
—
—
—
—
Estimate
12.12 M
15.03 M
22.18 M
25.38 M
26.90 M
28.79 M
32.52 M
38.48 M
40.70 M
44.73 M
48.37 M
51.90 M
Surprise
−5.36%
+27.90%
+1.47%
−4.51%
−3.45%
+1.00%
+2.24%
+8.69%
—
—
—
—